Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

XL019 - CAS# 945755-56-6 nin Reduction in prostaglandin E2 synthesis

SKU: 30637711272

4.7
PLN108.00 PLN136.00

Pay in 4 interest-free payments of $27.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Live Spec

XL019 - CAS# 945755-56-6 nin Reduction in prostaglandin E2 synthesisXL019 is an orally bioavailable inhibitor of Janus associated kinase 2 (JAK2) with potential antineoplastic activity. XL019 inhibits the activation of JAK2 as well as the mutated form JAK2V617F, which may result in the inhibition of the JAK STAT signaling pathway and may induce apoptosis. The JAK2 mutated form JAK2V617F has a valine to phenylalanine modification at position 617 and plays a key role in tumor cell proliferation and survival. Product

Store: tnailspamo.com · Domain: tnailspamo.com

Description

Reduction in prostaglandin E2 synthesis also led to reduced level of VEGF in plasma

McGreivy J

smell or taste

803712-67-6 (Obatoclax free base)

J Cardiovasc Pharmacol

XL019 - CAS# 945755-56-6 nin Reduction in prostaglandin E2 synthesisXL019 is an orally bioavailable inhibitor of Janus associated kinase 2 (JAK2) with potential antineoplastic activity. XL019 inhibits the activation of JAK2 as well as the mutated form JAK2V617F, which may result in the inhibition of the JAK STAT signaling pathway and may induce apoptosis. The JAK2 mutated form JAK2V617F has a valine to phenylalanine modification at position 617 and plays a key role in tumor cell proliferation and survival. Product

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products